DK142802C - - Google Patents

Info

Publication number
DK142802C
DK142802C DK97875A DK97875A DK142802C DK 142802 C DK142802 C DK 142802C DK 97875 A DK97875 A DK 97875A DK 97875 A DK97875 A DK 97875A DK 142802 C DK142802 C DK 142802C
Authority
DK
Denmark
Application number
DK97875A
Other languages
Danish (da)
Other versions
DK97875A (fr
DK142802B (da
Inventor
S Watanabe
M Kayano
Y Ishino
K Miyao
Original Assignee
Eisai Co Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd. filed Critical Eisai Co Ltd.
Publication of DK97875A publication Critical patent/DK97875A/da
Publication of DK142802B publication Critical patent/DK142802B/da
Application granted granted Critical
Publication of DK142802C publication Critical patent/DK142802C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
DK97875AA 1974-03-12 1975-03-11 Fremgangsmåde til fremstilling af terapeutiske præparater til indføring i mavesækken. DK142802B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2767374 1974-03-12
JP2767374A JPS5512411B2 (fr) 1974-03-12 1974-03-12

Publications (3)

Publication Number Publication Date
DK97875A DK97875A (fr) 1975-09-13
DK142802B DK142802B (da) 1981-02-02
DK142802C true DK142802C (fr) 1981-09-21

Family

ID=12227459

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97875AA DK142802B (da) 1974-03-12 1975-03-11 Fremgangsmåde til fremstilling af terapeutiske præparater til indføring i mavesækken.

Country Status (12)

Country Link
US (1) US3976764A (fr)
JP (1) JPS5512411B2 (fr)
BE (1) BE826498A (fr)
CA (1) CA1054056A (fr)
CH (1) CH604719A5 (fr)
DE (1) DE2510620C2 (fr)
DK (1) DK142802B (fr)
ES (1) ES435500A1 (fr)
FR (1) FR2263744B1 (fr)
GB (1) GB1507521A (fr)
NL (1) NL7502952A (fr)
SE (1) SE409286B (fr)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations
US4207890A (en) * 1977-01-04 1980-06-17 Mcneilab, Inc. Drug-dispensing device and method
JPS6024767B2 (ja) * 1979-08-24 1985-06-14 塩野義製薬株式会社 腸溶性硬カプセル剤
ATE34300T1 (de) * 1981-07-15 1988-06-15 Key Pharma Theophyllin mit verlaengerter abgabe.
US4451260A (en) * 1982-03-26 1984-05-29 Minnesota Mining And Manufacturing Company Sustained release oral medicinal delivery device
JPS5953410A (ja) * 1982-09-20 1984-03-28 Fujisawa Pharmaceut Co Ltd 新型ソフトカプセル剤
JPS59193831A (ja) * 1983-04-18 1984-11-02 Sankyo Co Ltd 腸溶性製剤の製造法
US4505890A (en) * 1983-06-30 1985-03-19 E. R. Squibb & Sons, Inc. Controlled release formulation and method
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
US4610870A (en) * 1984-10-05 1986-09-09 E. R. Squibb & Sons, Inc. Controlled release formulation
JPS61107782U (fr) * 1984-12-19 1986-07-08
US4735804A (en) * 1985-05-10 1988-04-05 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4767627A (en) * 1985-05-29 1988-08-30 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4758436A (en) * 1985-05-29 1988-07-19 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
US4756911A (en) * 1986-04-16 1988-07-12 E. R. Squibb & Sons, Inc. Controlled release formulation
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
DE3803482A1 (de) * 1988-02-05 1989-08-17 Lohmann Therapie Syst Lts Schwimmfaehiges orales therapeutisches system
JPH082781B2 (ja) * 1988-10-18 1996-01-17 嘉明 川島 中空顆粒状医薬及びその製法
JPH05507717A (ja) * 1990-06-25 1993-11-04 ザ・デュポン・メルク・ファーマシュウティカル・カンパニー 軟ゼラチンカプセル剤中で使用するための高められた溶解特性を有するアマンタジン塩酸塩懸濁液
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
US5198229A (en) * 1991-06-05 1993-03-30 Alza Corporation Self-retaining gastrointestinal delivery device
US5314696A (en) * 1991-06-27 1994-05-24 Paulos Manley A Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
JP2671257B2 (ja) * 1995-07-13 1997-10-29 エーザイ株式会社 溶解遅延性ゼラチン製剤組成物
SE9702533D0 (sv) 1997-07-01 1997-07-01 Astra Ab New oral formulation
IN186245B (fr) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
AP1224A (en) 1998-03-19 2003-11-14 Bristol Myers Squibb Co Biphasic controlled release delivery system for high solubility pharmaceuticals and method.
EP1245227A1 (fr) * 2001-03-31 2002-10-02 Jagotec Ag Comprimé pharmaceutique flottant dans l'estomac destiné à la libération programmée du principe actif et procédé pour produire le matériel flottant compris dans le comprimé
US20030203027A1 (en) * 2002-04-26 2003-10-30 Ethicon, Inc. Coating technique for deposition of drug substance on a substrate
US20040086566A1 (en) * 2002-11-04 2004-05-06 Alpharma, Inc. Waxy matrix dosage forms
US7485322B2 (en) * 2002-12-24 2009-02-03 Lek Pharmaceuticals D.D. Modified release pharmaceutical composition
EP1596841B1 (fr) * 2003-02-21 2008-10-08 LEK Pharmaceuticals D.D. Systeme therapeutique a base d'amoxicilline et d'acide clavulanique
JP2007510654A (ja) * 2003-11-04 2007-04-26 スパーナス ファーマシューティカルズ インコーポレイテッド 分極した酸素原子を有するポリマーを含むマトリクスからの正に荷電した薬理学的活性分子の徐放
CN101511346B (zh) * 2006-09-04 2012-07-04 万能药生物有限公司 可编制的漂浮递送技术
WO2009087665A2 (fr) * 2007-12-11 2009-07-16 Vishwanath Sudhir Nande Nouveau système d'administration de médicament à rétention gastrique
GB2460915B (en) 2008-06-16 2011-05-25 Biovascular Inc Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
JP2012500230A (ja) * 2008-08-18 2012-01-05 北京天衡▲薬▼物研究院 胃内滞留薬物放出システム及びその製造方法と使用
FR2945945B1 (fr) * 2009-05-29 2011-07-29 Flamel Tech Sa Procede de preparation de particules creuses et leurs applications
FR2945947B1 (fr) 2009-05-29 2011-07-29 Flamel Tech Sa Compositions pharmaceutiques flottantes a liberation controlee
CA2767143A1 (fr) * 2009-07-06 2011-01-13 Kyorin Pharmaceutical Co., Ltd. Comprime ayant une structure creuse
JP6019019B2 (ja) * 2010-07-05 2016-11-02 ヤゴテック アーゲー 剤形
WO2013009186A1 (fr) * 2011-07-14 2013-01-17 APET Holding B.V. Compositions de nicotinamide et leur utilisation thérapeutique
WO2013054285A1 (fr) 2011-10-11 2013-04-18 Ranbaxy Laboratories Limited Système de dosage de rétention gastrique et procédé de préparation de celui-ci
CA2879282C (fr) * 2012-07-16 2022-05-03 Hendrik Jan Cornelis Meijerink Systeme d'administration pharmacologique a retention gastrique
ES2536836T3 (es) 2012-10-12 2015-05-29 Omya International Ag Formulación de medicamento gastrorretentivo y sistemas de liberación y su método de preparación usando carbonato de calcio transformado en funcional
US20170266112A1 (en) 2014-06-11 2017-09-21 Massachusetts Institute Of Technology Residence structures and related methods
US10413507B2 (en) 2014-06-11 2019-09-17 Massachusetts Institute Of Technology Enteric elastomers
EP3034070A1 (fr) 2014-12-18 2016-06-22 Omya International AG Procédé pour la production d'un système d'administration pharmaceutique
EP3069713A1 (fr) 2015-03-20 2016-09-21 Omya International AG Forme posologique dispersible
CN104706613B (zh) * 2015-03-20 2018-01-16 华侨大学 一种胃漂浮空心缓释片的制备方法
EP3288604B1 (fr) 2015-05-01 2021-11-17 Massachusetts Institute of Technology Dispositifs d'induction à mémoire de forme pouvant être déclenchés
US11576859B2 (en) 2015-10-23 2023-02-14 Lyndra Therapeutics, Inc. Gastric residence systems for sustained release of therapeutic agents and methods of use thereof
KR20180090881A (ko) 2015-12-08 2018-08-13 린드라 인코퍼레이티드 위 체류 시스템을 위한 기하 구성형태
AU2017235598A1 (en) * 2016-03-18 2018-08-09 Grünenthal GmbH Floating pharmaceutical dosage form
EP3269361A1 (fr) 2016-07-14 2018-01-17 Omya International AG Forme posologique
CN110022861B (zh) 2016-09-30 2024-06-28 林德拉治疗公司 用于金刚烷类药物缓释的胃驻留系统
TWI811221B (zh) 2017-06-09 2023-08-11 美商萊恩卓治療公司 具有釋放速率調節膜之胃的滯留系統
US20220409490A1 (en) * 2020-03-02 2022-12-29 Craft Health Pte Ltd Method of manufacturing oral dosage forms for extended drug release
WO2023166225A1 (fr) * 2022-03-04 2023-09-07 APET Holding B.V. Formulations d'enzyme digestive

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3418999A (en) * 1964-02-12 1968-12-31 Donald W. Davis Method of swallowing a pill
FR1454013A (fr) * 1965-08-18 1966-07-22 Pluripharm Mode de présentation de deux médicaments associés
US3870790A (en) * 1970-01-22 1975-03-11 Forest Laboratories Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose

Also Published As

Publication number Publication date
DK97875A (fr) 1975-09-13
DE2510620C2 (de) 1984-01-05
NL7502952A (nl) 1975-09-16
BE826498A (fr) 1975-06-30
JPS5512411B2 (fr) 1980-04-02
US3976764A (en) 1976-08-24
GB1507521A (en) 1978-04-19
ES435500A1 (es) 1977-02-01
FR2263744A1 (fr) 1975-10-10
CH604719A5 (fr) 1978-09-15
FR2263744B1 (fr) 1978-11-24
JPS50121418A (fr) 1975-09-23
CA1054056A (fr) 1979-05-08
DK142802B (da) 1981-02-02
DE2510620A1 (de) 1975-09-18
SE7502725L (fr) 1975-09-15
SE409286B (sv) 1979-08-13

Similar Documents

Publication Publication Date Title
DK142802C (fr)
FR2286383B1 (fr)
FR2295727B1 (fr)
FR2290094B1 (fr)
JPS50116027A (fr)
FR2280657B1 (fr)
JPS50130331A (fr)
FR2294509B2 (fr)
JPS50112617A (fr)
JPS50122247A (fr)
JPS50114538A (fr)
JPS50126751U (fr)
JPS50120185U (fr)
CH580247A5 (fr)
BG20213A1 (fr)
CH577720A5 (fr)
CH577155A5 (fr)
CH579379A5 (fr)
CH576552B5 (fr)
CH579790B5 (fr)
CH576182A5 (fr)
CH579844A5 (fr)
CH580058A5 (fr)
CH576129A5 (fr)
BG20164A1 (fr)

Legal Events

Date Code Title Description
PBP Patent lapsed